Tony Butler
Stock Analyst at Rodman & Renshaw
(1.06)
# 3,557
Out of 4,732 analysts
107
Total ratings
34.62%
Success rate
-12.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $6.57 | +280.52% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $4.79 | +129.65% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $3.98 | +352.83% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $4.00 | +275.00% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $2.55 | +213.73% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.91 | +1,659.60% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.58 | +1,624.44% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.27 | +687.40% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $40.53 | +85.05% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $39.45 | -11.28% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $2.39 | +2,410.46% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $2.25 | +477.78% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $13.34 | +274.81% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.82 | +724.18% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.49 | +4,970.99% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.50 | +900.00% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.17 | +5,820.66% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.40 | +2,383.86% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $3.09 | +450.16% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $3.48 | +4,670.11% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $10.14 | +491.72% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.30 | +2,600.88% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.63 | +855.26% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $9 | $0.37 | +2,332.43% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $4.12 | -51.48% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $0.54 | +3,048.15% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.76 | +298.94% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $2.46 | +306.50% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.60 | +476.92% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $9.50 | +1,057.89% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.79 | +10,039.42% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $6.57
Upside: +280.52%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $4.79
Upside: +129.65%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $3.98
Upside: +352.83%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $4.00
Upside: +275.00%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $2.55
Upside: +213.73%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.91
Upside: +1,659.60%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.58
Upside: +1,624.44%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.27
Upside: +687.40%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $40.53
Upside: +85.05%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $39.45
Upside: -11.28%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $2.39
Upside: +2,410.46%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $2.25
Upside: +477.78%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $13.34
Upside: +274.81%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.82
Upside: +724.18%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.49
Upside: +4,970.99%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.50
Upside: +900.00%
Jul 31, 2023
Initiates: Buy
Price Target: $10
Current: $0.17
Upside: +5,820.66%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $0.40
Upside: +2,383.86%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $3.09
Upside: +450.16%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $3.48
Upside: +4,670.11%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $10.14
Upside: +491.72%
Jun 5, 2023
Reiterates: Buy
Price Target: $8
Current: $0.30
Upside: +2,600.88%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.63
Upside: +855.26%
Jun 1, 2023
Assumes: Buy
Price Target: $9
Current: $0.37
Upside: +2,332.43%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $4.12
Upside: -51.48%
May 25, 2023
Assumes: Buy
Price Target: $17
Current: $0.54
Upside: +3,048.15%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $3.76
Upside: +298.94%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $2.46
Upside: +306.50%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $2.60
Upside: +476.92%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $9.50
Upside: +1,057.89%
Mar 2, 2020
Initiates: Buy
Price Target: $80
Current: $0.79
Upside: +10,039.42%